Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node

European Journal of Surgical Oncology

Volumn 40, Issue 4, 2014, Pages 435-441

  Tvedskov, T F ^a   Meretoja, T J ^b   Jensen, M B ^a   Leidenius, M ^b   Kroman, N ^a  

^a Mental Health Center Glostrup   (Denmark)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Breast cancer; Isolated tumor cells; Micrometastases; Non sentinel node metastases; Sentinel node

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; DANISH BREAST CANCER COOPERATIVE GROUP MODEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HELSINKI MODEL; HIGH RISK PATIENT; HUMAN; ISOLATED TUMOR CELL; LOW RISK POPULATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; MIDDLE AGED; NON SENTINEL LYMPH NODE METASTASIS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR CELL; VALIDATION PROCESS;

BREAST CANCER; ISOLATED TUMOR CELLS; MICROMETASTASES; NON-SENTINEL NODE METASTASES; SENTINEL NODE;

ADULT; AGED; AREA UNDER CURVE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DENMARK; FEMALE; FINLAND; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM GRADING; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 84895929204     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.01.014     Document Type: Article

References (30)

1. C.H. van Deurzen, B.M. de, and E.M. Monninkhof et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node J Natl Cancer Inst 100 2008 1574 1580
2. G. Cserni, D. Gregori, and F. Merletti et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer Br J Surg 91 2004 1245 1252
3. V. Galimberti, B.F. Cole, and S. Zurrida et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial Lancet Oncol 14 2013 297 305
4. M.J. Pepels, B.M. de, and P. Bult et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells Ann Surg 255 2012 116 121
5. T.F. Tvedskov, M.B. Jensen, I.M. Lisse, B. Ejlertsen, E. Balslev, and N. Kroman High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node Int J Cancer 131 2012 2367 2375
6. K.J. Van Zee, D.M. Manasseh, and J.L. Bevilacqua et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 2003 1140 1151
7. C. Coutant, C. Olivier, and E. Lambaudie et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study J Clin Oncol 27 2009 2800 2808
8. A. Cyr, W.E. Gillanders, R.L. Aft, T.J. Eberlein, F. Gao, and J.A. Margenthaler Micrometastatic disease and isolated tumor cells as a predictor for additional breast cancer axillary metastatic burden Ann Surg Oncol 17 2010 303 311
9. A.S. Gur, B. Unal, and R. Johnson et al. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy J Am Coll Surg 208 2009 229 235
10. J. Rayhanabad, S. Yegiyants, K. Putchakayala, P. Haig, L. Romero, and L.A. DiFronzo Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes Am Surg 76 2010 1088 1091
11. S. Alran, R.Y. De, and V. Fourchotte et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy Ann Surg Oncol 14 2007 2195 2201
12. T.J. Meretoja, L. Strien, P.S. Heikkila, and M.H. Leidenius A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement Ann Surg Oncol 19 2012 567 576
13. G. Cserni, R. Bori, and R. Maraz et al. Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis Pathol Oncol Res 19 2013 95 101
14. Y. Andersson, J. Frisell, B.J. de, and L. Bergkvist Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: evaluation of the tenon score Breast Cancer (Auckl) 6 2012 31 38
15. L. Kocsis, M. Svebis, and G. Boross et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients Am Surg 70 2004 1019 1024
16. K. Chen, L. Zhu, and W. Jia et al. Validation and comparison of models to predict non-sentinel lymph node metastasis in breast cancer patients Cancer Sci 103 2012 274 281
17. G. Cserni, G. Boross, and R. Maraz et al. Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer Surg Oncol 21 2012 59 65
18. T.J. Meretoja, M.H. Leidenius, and P.S. Heikkila et al. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer J Natl Cancer Inst 104 2012 1888 1896
19. G. Houvenaeghel, C. Nos, and S. Giard et al. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis Eur J Surg Oncol 35 2009 690 695
20. L. Ouldamer, F. Arbion, A. Balagny, F. Fourquet, H. Marret, and G. Body Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram Breast 22 2013 787 792
21. S. Moller, M.B. Jensen, and B. Ejlertsen et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise Acta Oncol 47 2008 506 524
22. T.F. Tvedskov, M.B. Jensen, E. Balslev, and N. Kroman Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node Acta Oncol 53 2 2014 Feb 209 215
23. P. Christiansen, E. Friis, E. Balslev, D. Jensen, and S. Moller Sentinel node biopsy in breast cancer: five years experience from Denmark Acta Oncol 47 2008 561 568
24. R.F. Hwang, S. Krishnamurthy, and K.K. Hunt et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer Ann Surg Oncol 10 2003 248 254
25. D. Grabau, L. Dihge, M. Ferno, C. Ingvar, and L. Ryden Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution Eur J Surg Oncol 39 2013 601 607
26. T.F. Tvedskov, M.B. Jensen, and E. Balslev et al. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the Sentinel node Eur J Cancer 47 2011 S334
27. D.N. Krag, S.J. Anderson, and T.B. Julian et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 2010 927 933
28. F. Reyal, R. Rouzier, and B. pont-Hazelzet et al. The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma PLoS One 6 2011 e20297
29. F. Reyal, C. Belichard, and R. Rouzier et al. Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification PLoS One 7 2012 e47390
30. W. Zhou, Z. He, and J. Xue et al. Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes PLoS One 7 2012 e35881